ArticleOpen forum infectious diseases2021
Community Antibiotic Use at the Population Level During the SARS-CoV-2 Pandemic in British Columbia, Canada.
Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 24 citations in OpenAlex.
- Appropriateness and determinants of outpatient antibiotic use among migrants in British Columbia, Canada: a population-based study.JAC-antimicrobial resistance · 2026Article
- Non-pharmaceutical interventions restructured the upper respiratory bacterial microbiota in children under 2 during COVID-19: implications for infection control strategies.Frontiers in microbiology · 2026Article
- National retrospective study of regional prescriber-specific variation in community antibiotic prescribing Canada, 2019-2023.BMJ public health · 2026Article
- Article
- Article
- Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care.BMC pediatrics · 2023Article
- How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?Antibiotics (Basel, Switzerland) · 2023Article
- Impact of COVID-19 Pandemic on Antibiotic Utilisation in Malaysian Primary Care Clinics: An Interrupted Time Series Analysis.Antibiotics (Basel, Switzerland) · 2023Article
- Sex differences among users of NSAIDs and opioids during COVID-19 Pandemic.International journal of clinical pharmacy · 2023Article
- Community antibiotic prescriptions during COVID-19 era: a population-based cohort study among adults.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022Article
- A Time Series Analysis Evaluating Antibiotic Prescription Rates in Long-Term Care during the COVID-19 Pandemic in Alberta and Ontario, Canada.Antibiotics (Basel, Switzerland) · 2022Article
- Antibiotic use among COVID-19 patients in Hong Kong, January 2018 to March 2021.The Journal of infection · 2022Article
- Antimicrobial stewardship in non-COVID-19 patients with fever and respiratory symptoms in outpatient settings: Lessons from the "dynamic zero-COVID policy" in mainland China.The Journal of infection · 2022Article
- Surveillance of Antibacterial Usage during the COVID-19 Pandemic in England, 2020.Antibiotics (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe objective of this study was to examine the aggregate rates of antibiotic use at the population level and compare these rates over time against historical averages to identify the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting control measures on community prescribing.
methodsWe collected antibiotic prescriptions and physician office visits from January 1, 2016, to July 21, 2020. We calculated monthly prescription rates stratified by sex, age group, profession, diagnosis type, and antibiotic class. We looked at monthly prescription rate as a moving average over time. Using the interrupted time series analysis method, we estimated the changes in prescription rates after March 2020.
resultsThe moving average of overall monthly prescription rates during January-June 2020 was below the minimum of the historical years' moving averages (2016-2019). We observed a >30% reduction in overall monthly prescription rates in April, May, and July of 2020 compared with the same months of 2019. We observed that overall monthly prescription rates experienced a significant level change of -12.79 (
conclusionsIn British Columbia, Canada, overall and RTI-specific monthly antibiotic prescription rates declined significantly during April-July 2020 compared with the same months in prepandemic years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.